Christopher H Henry - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Christopher H Henry

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

ACG Case Reports Journal|October 6, 2023

Optimizing Endoscopy Education in Gastroenterology FellowshipDivya M Chalikonda, Christopher H Henry

ACG Case Reports Journal|May 5, 2016

Tracheobronchitis in a Patient With Crohn's DiseaseVincent Yeung, Anusha G Govind, Sanaa Arastu, et al.

Cancer Biology & Therapy|October 11, 2021

Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteersDavid S Weinberg, Nathan R Foster, Gary Della'Zanna, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

ACG Case Reports Journal|October 6, 2023

Optimizing Endoscopy Education in Gastroenterology FellowshipDivya M Chalikonda, Christopher H Henry

ACG Case Reports Journal|May 5, 2016

Tracheobronchitis in a Patient With Crohn's DiseaseVincent Yeung, Anusha G Govind, Sanaa Arastu, et al.

Cancer Biology & Therapy|October 11, 2021

Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteersDavid S Weinberg, Nathan R Foster, Gary Della'Zanna, et al.

Pageof 1